Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Allogene Therapeutics (ALLO) Q3 2026 Earnings
ALLO
5
Aug
Confirmed
Q3 2025
Q4 2025
Q2 2026
Next
-0.27
-0.24
-0.2
-0.17
Details
Expected EPS
-0.169723
Actual EPS
N/A
Surprise EPS
0.17
Surprise Percent
+100%
Description
Allogene Therapeutics (ALLO) will report earnings of for Q3 2026 on August 05, 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login